Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23450,98,1.76 [0.93-3.34],0.084890178990629
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24088,181,0.83 [0.50-1.41],0.4962583243967846
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23849,1162,1.32 [1.08-1.61],0.0063127032748375
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,24115,412,1.15 [0.82-1.62],0.4188870163118606
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23367,3054,1.05 [0.93-1.19],0.4304326930030192
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23572,2478,1.24 [1.08-1.42],0.0028727589818116
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23865,1178,0.93 [0.75-1.14],0.4601702592265274
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24017,80,0.68 [0.31-1.52],0.3477577183360162
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22526,706,1.65 [1.29-2.12],7.20322606296533e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21755,800,1.67 [1.32-2.10],1.6579305860612602e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21811,219,1.54 [0.98-2.42],0.0614177751995484
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16897,1430,1.26 [1.05-1.52],0.0146385696828605
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21607,317,1.32 [0.90-1.94],0.1551973111575625
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24057,1370,0.96 [0.80-1.16],0.6960917234568715
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Mycoses,24168,465,1.03 [0.74-1.42],0.8806569796005048
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23513,826,1.36 [1.08-1.72],0.0095504517753597
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24126,774,1.68 [1.34-2.12],9.847732428535511e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22868,181,0.84 [0.50-1.42],0.5143960603027209
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24226,39,1.25 [0.42-3.74],0.6857992400082664
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24037,685,1.72 [1.35-2.20],1.290659361167517e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24013,76,0.95 [0.43-2.09],0.904543851940414
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24141,169,0.96 [0.56-1.65],0.8962686636715508
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24126,154,1.07 [0.61-1.87],0.8209067341372468
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22982,295,1.47 [1.00-2.16],0.0523181173730082
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22912,225,0.76 [0.47-1.21],0.2507332385538784
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22789,102,1.30 [0.67-2.53],0.4441238043600858
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24203,34,1.28 [0.41-3.98],0.6738807893371401
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24159,142,0.96 [0.53-1.73],0.8886407745481569
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral warts,24060,43,1.04 [0.36-3.01],0.9487005788777504
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24087,70,0.94 [0.40-2.18],0.8786551136123589
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm,23979,210,1.09 [0.68-1.76],0.7156940049423559
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24133,63,0.94 [0.39-2.25],0.8827642155524852
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24125,59,0.65 [0.26-1.60],0.3431070558866731
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23968,1069,0.85 [0.68-1.05],0.1383495961746409
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of meninges,24202,74,0.73 [0.32-1.67],0.4568811482982379
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24165,59,0.39 [0.16-0.99],0.0472051781751326
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24194,118,1.23 [0.66-2.29],0.522153030554731
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of ovary,24158,150,0.73 [0.41-1.30],0.2836049275824766
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24206,243,0.99 [0.63-1.56],0.978818550748543
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Caecum,24212,224,0.76 [0.47-1.22],0.2550101875132378
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24144,57,1.48 [0.62-3.56],0.3750004881454727
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,24210,133,0.75 [0.40-1.38],0.3509433829747553
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Rectum,24171,248,0.98 [0.63-1.54],0.935430516907437
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24124,447,0.90 [0.64-1.25],0.527019255932353
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24211,256,1.12 [0.73-1.72],0.6090651001499654
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Carcinoma in situ of breast,19600,119,0.99 [0.52-1.88],0.9709115976509084
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19673,140,0.85 [0.47-1.55],0.6035474324164789
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19667,31,3.48 [1.42-8.50],0.0062575693782229
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19694,58,1.25 [0.51-3.04],0.6290940007110355
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24163,127,1.10 [0.59-2.04],0.7712766500115963
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma, any site",24164,125,1.07 [0.57-2.00],0.8386860910797542
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Leiomyoma of uterus,23347,511,0.86 [0.63-1.17],0.323594765222769
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lung cancer and mesothelioma,17388,286,2.02 [1.24-3.28],0.0045979292061714
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lymphoid leukaemia,19669,33,2.93 [1.14-7.52],0.0251621870634084
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19792,156,0.87 [0.49-1.54],0.6334521658853121
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19732,96,0.95 [0.46-1.97],0.8946106840328021
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19806,170,1.04 [0.61-1.75],0.8930592229372825
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19699,63,2.01 [0.95-4.26],0.0694852929969834
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19698,62,1.02 [0.42-2.47],0.9736755090598171
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19684,48,1.39 [0.54-3.56],0.4943243446166178
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19767,131,2.10 [1.25-3.52],0.0050707710105486
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19730,94,0.74 [0.36-1.52],0.4081626445722154
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19711,75,1.19 [0.54-2.63],0.6645574390299069
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19671,35,2.14 [0.81-5.69],0.1268295811416105
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19709,73,1.84 [0.87-3.91],0.1113013227958633
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi,23995,208,1.15 [0.70-1.88],0.5800256898761433
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi of trunk,24185,69,1.33 [0.57-3.12],0.5094734263928464
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanoma in situ,19665,77,0.80 [0.35-1.82],0.5964961977498404
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19708,72,1.52 [0.70-3.29],0.2900943593834645
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19770,134,1.24 [0.69-2.23],0.4781647005282569
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19846,210,1.80 [1.22-2.65],0.0030343921834256
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19719,83,1.19 [0.56-2.53],0.6556600104149457
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Other benign neoplasms of skin,24026,153,0.99 [0.56-1.75],0.9699324912340412
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20453,817,0.99 [0.78-1.27],0.9646228799005168
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20488,852,0.99 [0.77-1.26],0.9143720783423168
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23945,343,1.68 [1.18-2.41],0.0041131433971627
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22475,86,2.30 [1.21-4.36],0.0105621894468395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23673,71,0.87 [0.38-2.01],0.7524298380372033
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23333,2598,1.00 [0.87-1.15],0.9491457647632976
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22809,28,1.05 [0.29-3.82],0.9360621829921766
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23878,45,0.92 [0.33-2.58],0.8782345309198866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23707,1318,1.09 [0.90-1.32],0.4023509135481304
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23707,1318,1.09 [0.90-1.32],0.4023509135481304
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22457,68,2.14 [1.01-4.55],0.0478157681748752
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23866,1085,1.05 [0.85-1.30],0.640723396442702
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23935,102,1.66 [0.87-3.17],0.1276829040922704
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23649,47,1.55 [0.59-4.06],0.3680121791347766
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23654,52,1.77 [0.71-4.43],0.2237260960313057
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24038,205,1.53 [0.96-2.43],0.0714579657394735
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24129,53,0.51 [0.20-1.31],0.1611731675872051
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24008,175,1.78 [1.09-2.90],0.0216747068518289
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22893,112,0.54 [0.27-1.07],0.0796042179306109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19542,212,1.29 [0.80-2.07],0.2962039723760685
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22968,59,1.38 [0.55-3.49],0.4924163043241311
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22965,56,1.01 [0.39-2.61],0.9870654083591024
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19373,43,2.47 [1.04-5.85],0.0404948577191182
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22216,54,1.21 [0.47-3.11],0.691994928827914
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21929,211,0.68 [0.42-1.12],0.1309909674331395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23840,425,1.10 [0.79-1.54],0.5612359486409466
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23676,261,1.37 [0.90-2.07],0.139386912723113
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23476,61,1.11 [0.46-2.68],0.8228835024200843
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23887,1725,1.12 [0.95-1.33],0.1819791487618608
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21484,1687,1.13 [0.96-1.34],0.1522545813723145
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19376,46,3.25 [1.49-7.05],0.0029294894480205
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21538,102,1.45 [0.75-2.79],0.2692597926752745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19583,253,1.29 [0.83-1.98],0.2541693912812599
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19371,41,1.96 [0.69-5.54],0.2042418594927405
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22090,2760,1.20 [1.05-1.37],0.0060158589636493
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19516,186,1.83 [1.14-2.94],0.0125036603832865
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19812,482,1.64 [1.21-2.21],0.0014443220829564
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24139,315,0.80 [0.54-1.19],0.2796660450498727
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23970,146,1.32 [0.75-2.30],0.334692483205081
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19420,90,2.76 [1.51-5.05],0.0009533352950711
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19380,50,2.33 [0.97-5.59],0.0591874478862912
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23452,2016,1.07 [0.92-1.25],0.3992054745658012
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19508,178,2.25 [1.46-3.47],0.0002275897891526
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19500,170,1.38 [0.83-2.30],0.2133604895120527
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19796,466,1.22 [0.88-1.67],0.2290573995520616
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19403,73,1.66 [0.77-3.59],0.1943800498691072
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23964,140,1.30 [0.73-2.30],0.3680861274867991
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19869,539,1.50 [1.12-2.01],0.00589408198663
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19818,488,1.32 [0.96-1.80],0.0829167352136651
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21782,64,3.04 [1.56-5.92],0.0010495995116392
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23450,4120,1.23 [1.11-1.37],0.000135674560253
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21502,66,0.55 [0.23-1.28],0.1652255771073015
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21515,79,0.94 [0.42-2.08],0.8749129870528886
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24056,1807,0.90 [0.77-1.05],0.1899952685504399
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24060,1806,0.91 [0.77-1.06],0.2256747426328326
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21509,73,0.96 [0.43-2.16],0.9251552497773105
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23861,1392,1.15 [0.96-1.39],0.1303810392851421
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20640,1310,1.30 [1.07-1.57],0.0069513249408193
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24215,157,1.31 [0.77-2.24],0.3128379679604887
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23456,41,0.47 [0.15-1.43],0.1808752939187634
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22590,121,1.34 [0.72-2.48],0.3555544770059821
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22643,174,0.62 [0.36-1.05],0.0757403887367659
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19545,215,0.82 [0.51-1.33],0.4266865529456605
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22618,122,1.74 [0.96-3.15],0.0677853848528532
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1502,38,2.09 [0.95-4.59],0.0660918875485293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1596,150,1.19 [0.71-1.97],0.5094681054661665
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22521,25,1.94 [0.53-7.12],0.3158557794274342
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1486,23,2.26 [0.89-5.76],0.0861499250707476
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23809,1313,1.07 [0.89-1.29],0.4950047627809735
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23711,296,0.99 [0.66-1.48],0.951137951640146
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22135,417,1.12 [0.80-1.56],0.504805080123748
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19961,631,1.30 [0.99-1.71],0.0593655376104841
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24137,209,0.93 [0.57-1.51],0.7755751835485817
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23326,44,2.50 [0.97-6.43],0.0582600022761207
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Angina pectoris,22876,758,1.06 [0.82-1.36],0.6715250712436382
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23363,81,1.87 [0.88-3.95],0.1014641062797408
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23312,30,1.50 [0.42-5.27],0.5303154087791071
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23420,138,2.17 [1.29-3.68],0.0037337768026742
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15748,1291,1.52 [1.26-1.85],2.06132729411868e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,AV-block,21238,212,1.21 [0.75-1.96],0.4390733509147281
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24184,268,1.62 [1.08-2.42],0.0202968570446181
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,14566,109,0.76 [0.38-1.51],0.4344921961376635
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21146,120,1.32 [0.70-2.50],0.3848441311714361
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21098,72,1.21 [0.53-2.75],0.652030271184471
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24222,28,0.51 [0.13-2.00],0.330983105657874
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Conduction disorders,21667,641,1.40 [1.07-1.84],0.0147136939624731
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23416,1308,1.32 [1.09-1.59],0.0036742908844683
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21801,6427,1.09 [1.00-1.19],0.0576368629439605
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22915,222,1.11 [0.69-1.78],0.6724112541920892
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Endocarditis,21072,46,2.32 [0.98-5.50],0.0568510187676831
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24139,733,1.91 [1.52-2.40],2.7620887170085443e-08
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertension,22354,5411,0.99 [0.90-1.08],0.7620990037440338
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22362,5419,0.99 [0.90-1.08],0.760067450043463
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24123,35,3.73 [1.84-7.57],0.0002710967643821
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",17095,152,3.72 [2.57-5.39],3.2169460255551348e-12
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,17010,67,1.58 [0.72-3.47],0.2544492426693424
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypotension,24108,929,1.19 [0.95-1.49],0.1243332569893818
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23559,85,0.89 [0.42-1.91],0.7697979409232808
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23597,1479,1.26 [1.06-1.50],0.0104250908493074
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23949,402,1.14 [0.81-1.60],0.4662957281975796
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21298,272,1.70 [1.14-2.52],0.0092262835193261
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24031,530,1.34 [1.00-1.79],0.0516166219712743
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22542,424,1.32 [0.95-1.84],0.0957477843092104
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24201,77,2.26 [1.21-4.20],0.0103905037761619
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24218,208,1.18 [0.74-1.90],0.4889649894482932
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,22727,34,4.20 [1.65-10.66],0.0025512106624629
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other aneurysm,23331,49,1.83 [0.70-4.82],0.2202977168754043
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,21341,315,1.23 [0.83-1.84],0.2985503863090722
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23343,61,1.00 [0.40-2.50],0.9943273890269684
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23457,175,1.88 [1.14-3.11],0.0133109301576106
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21174,148,1.31 [0.74-2.32],0.3544574486342411
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,22769,76,1.30 [0.58-2.89],0.5238631570385566
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22734,41,0.67 [0.22-2.03],0.4826241134166514
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23126,32,0.92 [0.26-3.19],0.8895027303170223
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22830,137,1.46 [0.81-2.63],0.202247354921901
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21708,682,1.58 [1.22-2.04],0.0004457050305487
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23215,36,1.26 [0.40-3.97],0.690123169672469
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23732,450,1.51 [1.09-2.09],0.0124335746381806
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23716,289,3.04 [2.26-4.07],1.3324161280652372e-13
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23567,473,1.03 [0.75-1.41],0.8703291365113377
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14711,254,1.42 [0.92-2.20],0.1179831640589084
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23517,247,1.76 [1.15-2.71],0.009885263767303
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22983,290,1.00 [0.66-1.51],0.9911948410008063
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23814,387,1.12 [0.78-1.60],0.5381985861845549
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24154,509,1.67 [1.25-2.22],0.0004472865212479
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21215,189,1.11 [0.66-1.86],0.6890595634869734
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23709,282,2.98 [2.21-4.02],9.638229672836817e-13
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23230,136,1.22 [0.68-2.19],0.5094725547447798
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23940,466,1.11 [0.81-1.53],0.5208742715990926
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23916,508,1.19 [0.88-1.61],0.258816794489957
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23528,64,2.05 [1.00-4.22],0.0504618847448039
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23319,37,2.20 [0.75-6.44],0.1488145177096924
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23733,186,0.85 [0.51-1.43],0.5499783078591812
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23678,177,1.13 [0.68-1.90],0.6294034382787156
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Varicose veins,23077,384,1.17 [0.81-1.67],0.4019858424281569
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23290,83,1.12 [0.51-2.45],0.7786004805377187
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24040,614,1.05 [0.79-1.40],0.7115653578615522
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24188,196,1.31 [0.80-2.15],0.288599271835581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21533,1627,1.11 [0.93-1.32],0.2377603036821381
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Any mental disorder,23703,3797,1.11 [0.99-1.25],0.0658542704128015
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24162,232,1.17 [0.74-1.86],0.5021839115235731
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21649,1743,1.13 [0.95-1.33],0.1643499608857161
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19985,79,0.68 [0.31-1.51],0.3405655552926457
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Smoking dependency,23866,1053,1.32 [1.07-1.62],0.0088508991421375
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21125,1219,1.25 [1.03-1.51],0.0259952775167311
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Vascular dementia,23796,92,0.75 [0.36-1.58],0.4491704394725317
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Alzheimer disease,24224,324,1.19 [0.81-1.74],0.3672863160823639
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16605,52,1.58 [0.66-3.75],0.3037463514328636
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Bell's palsy,22341,71,1.24 [0.55-2.80],0.6032810795157519
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22833,563,1.06 [0.79-1.42],0.7069325377383371
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral cysts,23872,190,1.03 [0.62-1.71],0.9155951109059992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24159,241,1.50 [0.98-2.29],0.061539829261211
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23799,39,1.23 [0.41-3.68],0.7067963007124156
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24213,44,1.15 [0.41-3.26],0.7907506857280814
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23727,45,2.28 [0.93-5.63],0.072889515139221
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Epilepsy,22941,250,1.55 [1.00-2.38],0.0479111630476273
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23854,1163,1.20 [0.98-1.47],0.0795735139218059
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24180,309,1.04 [0.70-1.54],0.8628382944064786
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23681,2541,1.01 [0.88-1.16],0.9263041379133754
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,23901,42,3.33 [1.46-7.60],0.0042510755493233
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hemiplegia,24109,191,1.52 [0.95-2.44],0.0819475829665598
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hydrocephalus,23738,56,2.15 [0.98-4.73],0.0574943807681401
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24206,66,1.06 [0.45-2.49],0.8982101634280789
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22382,112,0.96 [0.49-1.88],0.9002517632162487
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22324,54,0.96 [0.37-2.50],0.9254819872017204
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Memory loss,23685,93,0.56 [0.27-1.17],0.1241483250665713
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Migraine,23134,443,1.08 [0.77-1.51],0.6425967075052772
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24124,400,1.13 [0.80-1.61],0.4894513469921623
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Motor neuron disease,16692,115,0.98 [0.50-1.90],0.9444091800651792
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24023,128,0.95 [0.50-1.78],0.8635600390534978
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23496,1226,0.98 [0.80-1.20],0.8280226470422019
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Neurological diseases,22806,3258,1.07 [0.95-1.21],0.2726783119806777
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23886,126,1.45 [0.81-2.61],0.2146655731993204
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22645,375,0.73 [0.51-1.06],0.098365434638283
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24173,200,3.01 [2.06-4.39],1.3148262804020016e-08
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19608,584,1.17 [0.87-1.56],0.2946151453761543
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23741,59,0.80 [0.32-1.99],0.6304370891349471
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23794,112,1.08 [0.56-2.07],0.824516039671421
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24013,142,1.38 [0.78-2.44],0.2695066621444547
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22349,79,1.07 [0.49-2.33],0.8711891013515694
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other headache syndromes,22759,68,1.94 [0.90-4.19],0.0923804093979031
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other neurological diseases,24122,440,1.07 [0.76-1.48],0.7088098734211985
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other sleep disorders,23041,350,1.32 [0.92-1.90],0.1303046270786991
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Parkinson's disease,24201,146,0.88 [0.49-1.58],0.6782253647092062
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23754,72,0.67 [0.29-1.55],0.3498097489417532
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,24223,76,1.34 [0.61-2.96],0.4658561992590595
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Sleep apnoea,24067,281,1.29 [0.86-1.93],0.2120179717542109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24007,34,4.50 [2.31-8.78],1.0049152760574086e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24214,140,1.32 [0.74-2.35],0.3458585210196309
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22331,61,1.09 [0.45-2.68],0.8459137308076776
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24224,327,1.19 [0.81-1.74],0.3720389296500144
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23756,89,0.74 [0.35-1.58],0.4335914441791796
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23705,93,0.76 [0.36-1.61],0.4802866803042003
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23818,431,1.25 [0.90-1.73],0.1796898075109622
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24097,143,1.13 [0.65-1.98],0.6555925893618284
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23247,53,1.05 [0.40-2.75],0.9178928363158724
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23243,49,0.73 [0.26-2.01],0.5367264588691523
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24112,58,1.44 [0.60-3.46],0.418719884587469
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23970,152,0.88 [0.50-1.56],0.6594527444827345
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1493,29,2.26 [0.92-5.57],0.0758771605824681
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1786,57,2.26 [1.20-4.24],0.0111694696541256
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23695,83,2.21 [1.14-4.25],0.018128392788559
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24072,928,1.14 [0.91-1.42],0.2686646694207466
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23851,657,1.02 [0.78-1.34],0.8958031367520334
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23460,266,0.93 [0.61-1.42],0.7291761088615307
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24148,761,1.24 [0.97-1.59],0.0839457605811818
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24213,64,1.97 [0.90-4.34],0.0899991822555072
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24081,694,1.15 [0.89-1.49],0.29563524303843
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24185,367,1.13 [0.79-1.62],0.512888784544841
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24137,186,0.98 [0.59-1.63],0.944853884326314
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23231,37,0.71 [0.22-2.25],0.5579274160233316
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23237,43,1.29 [0.47-3.54],0.6166610952265248
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23255,61,0.51 [0.20-1.27],0.1485133365397261
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24146,630,1.13 [0.86-1.48],0.3968543572488365
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23670,154,0.90 [0.51-1.58],0.7101983595232351
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23445,58,0.95 [0.38-2.38],0.9201932435472482
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23909,91,1.91 [0.98-3.74],0.0578019691837416
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24103,285,1.02 [0.67-1.54],0.9258844846178064
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23572,185,1.21 [0.73-2.02],0.4534404273667011
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24071,120,0.84 [0.45-1.60],0.6029948271201331
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23927,411,1.18 [0.84-1.65],0.345938306455142
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23748,136,1.81 [1.04-3.15],0.0343238380907226
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22639,2252,0.97 [0.84-1.12],0.6458637110878664
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24069,251,1.01 [0.65-1.57],0.965208690453294
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24202,143,1.56 [0.89-2.72],0.1173799699325435
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23530,336,1.05 [0.72-1.53],0.8056438073391501
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23877,59,1.97 [0.86-4.54],0.1107894150293456
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24199,50,2.26 [0.96-5.32],0.0613764710835908
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23279,85,1.53 [0.74-3.15],0.2490723164515721
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23321,127,0.81 [0.43-1.53],0.5167570306367397
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23239,95,1.06 [0.52-2.15],0.8715601920935675
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23444,57,3.30 [1.61-6.75],0.0010790872752924
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23203,59,1.55 [0.65-3.71],0.3268596215485056
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23621,105,0.98 [0.50-1.95],0.964827099895616
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23675,159,1.08 [0.62-1.86],0.7945219262338228
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23306,112,1.32 [0.70-2.51],0.3893077954142363
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23226,82,1.15 [0.53-2.50],0.7264116188865346
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23205,61,0.92 [0.38-2.23],0.851131141474827
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22232,1845,1.07 [0.92-1.26],0.375322084372563
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23273,79,1.38 [0.64-2.95],0.4084189453567802
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23990,378,1.43 [1.01-2.02],0.042384196772888
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23652,40,0.80 [0.26-2.43],0.6922710910822283
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23762,150,1.41 [0.82-2.43],0.215427761757346
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23997,103,0.69 [0.35-1.39],0.2993467281792967
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24182,95,0.90 [0.43-1.85],0.7671247847538174
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24113,127,0.72 [0.38-1.34],0.2979018746953353
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23959,65,0.78 [0.33-1.87],0.5820217601983524
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23960,66,1.56 [0.69-3.56],0.2851461308465786
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24130,713,0.96 [0.73-1.24],0.7349564385635032
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23903,486,1.03 [0.75-1.41],0.8645913272082564
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23521,104,0.68 [0.34-1.36],0.2772592869742954
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23494,77,1.31 [0.60-2.87],0.5027729070063287
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,23977,76,1.05 [0.47-2.32],0.9079648047849992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24113,212,1.53 [0.96-2.44],0.0716336238820764
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23958,57,2.46 [1.07-5.66],0.0333880949225499
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza,22732,114,1.72 [0.96-3.09],0.070099824448788
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22731,113,1.70 [0.94-3.06],0.079353225428817
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17218,116,0.62 [0.32-1.21],0.1584038692892943
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,24099,252,0.81 [0.52-1.26],0.3431575283978425
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18783,1844,0.79 [0.67-0.94],0.0068560973905897
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18922,1820,0.78 [0.66-0.93],0.0045621235159146
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23863,116,1.51 [0.82-2.77],0.1843393609826634
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22680,62,1.83 [0.84-4.02],0.1301777720521328
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bronchiectasis,20916,356,1.39 [0.97-1.98],0.071906134265681
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20622,62,0.93 [0.38-2.29],0.8800781172514253
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23195,2635,0.89 [0.77-1.02],0.0918848316114502
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23096,59,1.61 [0.67-3.85],0.2856889216945221
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,23168,131,2.22 [1.28-3.85],0.0043310246650074
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24070,915,1.21 [0.97-1.52],0.0898516683623674
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,23104,67,0.89 [0.37-2.13],0.7941936387152767
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22362,4535,1.08 [0.97-1.20],0.1402224971845915
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23331,294,0.85 [0.56-1.28],0.4276482836309224
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Early onset COPD,23441,286,1.57 [1.06-2.34],0.0251845866109402
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Emphysema,20795,235,1.39 [0.91-2.13],0.1240707451839782
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22734,203,1.78 [1.14-2.77],0.0111577535762551
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24046,1428,1.43 [1.20-1.71],6.274442674079417e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22770,239,1.59 [1.04-2.42],0.0319490633052769
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Later onset COPD,23399,629,1.11 [0.85-1.46],0.442005907656356
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24218,191,1.30 [0.80-2.12],0.2900271154162987
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Nasal polyp,23098,61,0.85 [0.34-2.12],0.7338847945170721
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24019,822,1.06 [0.83-1.35],0.6596669543071378
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,24055,1534,1.54 [1.30-1.84],8.638953282502359e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23732,695,0.97 [0.74-1.26],0.8091560426519935
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other pleural conditions,22556,35,0.55 [0.16-1.87],0.339645967009326
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24148,303,1.50 [1.02-2.20],0.0393051326309773
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24145,1047,1.44 [1.17-1.78],0.0006846043579378
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural effusion,23246,725,1.44 [1.11-1.86],0.0062498634860715
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural plaque,22564,43,1.18 [0.39-3.55],0.7727977873569248
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23833,1215,1.53 [1.27-1.85],8.498317671031452e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24192,165,1.17 [0.68-1.99],0.5719518154947238
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumothorax,22610,89,1.04 [0.49-2.24],0.9112113427090244
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pollen allergy,24199,211,0.91 [0.56-1.47],0.6889876401769139
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,23899,54,1.20 [0.47-3.06],0.706506625308888
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17145,43,6.28 [2.25-17.53],0.0004554962517483
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24000,803,1.08 [0.84-1.38],0.5504678108961495
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23289,252,0.80 [0.51-1.26],0.3411856890373469
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Viral pneumonia,22802,184,0.85 [0.50-1.42],0.5300183953005713
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23869,145,0.76 [0.42-1.36],0.3570397928200238
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11664,90,1.34 [0.68-2.65],0.4053135434000197
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17327,36,1.30 [0.40-4.19],0.6600076208895063
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute appendicitis,24054,123,0.88 [0.46-1.67],0.6906827400089418
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute gastritis,18195,73,0.81 [0.35-1.89],0.6338028082670939
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,22203,142,1.00 [0.55-1.79],0.9895632745779503
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute peritonitis,23715,73,0.74 [0.32-1.69],0.4693217333145623
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23462,31,1.34 [0.39-4.64],0.6463587573524134
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,18427,305,0.70 [0.47-1.06],0.0956523174992573
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22134,73,1.83 [0.88-3.81],0.1054876206390366
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23849,73,1.83 [0.87-3.84],0.1104452028863317
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholecystitis,22218,157,1.04 [0.60-1.82],0.890026637957723
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholelithiasis,23119,1058,0.91 [0.74-1.13],0.414239847580252
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic gastritis,18419,297,1.05 [0.70-1.58],0.8020414750178324
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22097,36,2.95 [1.23-7.07],0.015615060501704
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24154,66,2.48 [1.25-4.94],0.0094737740939737
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Coeliac disease,22875,131,1.13 [0.61-2.09],0.696582905341081
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Collagenous colitis,22548,95,1.67 [0.86-3.23],0.1272427077768244
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24097,143,0.69 [0.38-1.25],0.2217058414982893
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Constipation,23922,1491,0.95 [0.79-1.14],0.5555337404130707
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn disease,22526,73,1.31 [0.58-2.98],0.5128625400618355
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23900,50,1.67 [0.65-4.33],0.2890619048468363
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22529,76,1.05 [0.46-2.37],0.9082718961110512
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Dental caries,23496,203,0.88 [0.54-1.44],0.605376897429101
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22776,2157,0.96 [0.82-1.12],0.5822638592510825
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of appendix,24092,161,0.89 [0.51-1.56],0.6907821534696148
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of liver,24136,705,1.17 [0.90-1.52],0.2286488676183101
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22191,4069,1.04 [0.93-1.16],0.5007459494152087
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23812,519,1.01 [0.74-1.38],0.9432428897335838
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24114,472,1.02 [0.74-1.40],0.9195912906777004
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23399,106,1.34 [0.69-2.61],0.3916157936241062
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23265,57,1.50 [0.62-3.62],0.3710339183744809
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23965,1221,1.20 [0.98-1.46],0.071561923541238
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of tongue,23270,92,0.83 [0.39-1.74],0.615630936602523
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23469,1408,0.95 [0.79-1.15],0.6166030524965405
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20110,2819,0.85 [0.74-0.97],0.0195959434825098
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,18239,117,1.04 [0.54-1.98],0.9160869669071628
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24176,97,1.00 [0.50-2.02],0.9984921418868324
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24136,56,1.03 [0.39-2.69],0.9522671103568582
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23514,83,1.78 [0.90-3.54],0.098956140410859
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17396,105,1.04 [0.52-2.08],0.9187636105245928
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,18710,588,0.85 [0.63-1.13],0.26378211661015
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastric ulcer,18428,306,1.18 [0.79-1.75],0.4258238222766682
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20577,2455,1.04 [0.90-1.20],0.5823554427079816
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18541,419,1.09 [0.77-1.53],0.6249276246621067
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18950,7415,0.99 [0.91-1.08],0.8784867697645768
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,GI-bleeding,23716,972,1.23 [0.99-1.53],0.066209883540915
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23354,61,2.05 [0.93-4.54],0.0761668908226931
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18151,1118,0.96 [0.77-1.18],0.6872356200962595
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23464,33,1.25 [0.39-4.02],0.7105902175351747
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Hernia,23164,2545,0.95 [0.83-1.09],0.4871855763992408
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impacted teeth,24145,52,1.11 [0.41-2.99],0.842416555752938
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impaction of intestines,17352,61,0.92 [0.37-2.30],0.8517951867759845
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Inguinal hernia,20771,152,0.67 [0.37-1.19],0.1695826551066465
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17379,88,1.53 [0.74-3.17],0.2492260466863755
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22900,156,1.10 [0.63-1.94],0.7369896881782914
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18002,711,0.88 [0.68-1.16],0.3675169836308242
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24213,303,1.08 [0.73-1.61],0.7066995348011053
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23175,722,1.10 [0.85-1.43],0.4769456698177494
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23418,965,1.09 [0.87-1.37],0.4506650047477638
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18256,134,0.59 [0.32-1.09],0.0931739926605948
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophagitis,18629,507,0.79 [0.57-1.08],0.1445334561494788
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24182,143,1.95 [1.15-3.31],0.0128713364686336
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20673,54,2.41 [1.05-5.53],0.0379262203131372
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18403,1112,0.91 [0.73-1.13],0.391718742239967
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22322,261,1.18 [0.77-1.80],0.4554892644708315
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22228,167,0.86 [0.50-1.49],0.5911782362470995
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,18685,1394,1.03 [0.85-1.24],0.7843098933594113
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,22304,5013,0.96 [0.87-1.06],0.4331238534734607
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23269,206,1.53 [0.96-2.44],0.0742916332757199
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of liver,24017,586,1.21 [0.92-1.61],0.1784420458663917
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18646,524,0.75 [0.55-1.02],0.0664873841739897
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22198,137,1.00 [0.55-1.80],0.9874682399896866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24058,416,1.13 [0.80-1.59],0.492086812767521
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19070,948,1.11 [0.88-1.39],0.3892154791350545
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23732,988,1.21 [0.97-1.51],0.0860830151474649
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23449,156,0.95 [0.54-1.67],0.8659077767655131
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18833,1542,0.96 [0.80-1.15],0.6299771181323315
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19977,1855,1.08 [0.92-1.27],0.3714933071738817
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23525,94,1.80 [0.93-3.49],0.0822966461652667
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23307,854,1.17 [0.92-1.49],0.1870389824254003
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17587,296,1.74 [1.17-2.58],0.0065307472187134
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24127,65,0.85 [0.35-2.09],0.7306467962688487
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17735,444,1.41 [1.01-1.96],0.043168870188895
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22866,122,1.12 [0.60-2.10],0.7213999098970489
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24216,64,2.15 [0.99-4.66],0.0531019703421676
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23295,117,1.31 [0.69-2.48],0.405534944022518
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Toxic colitis,22508,55,2.10 [0.95-4.66],0.0684031542444456
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18332,210,0.87 [0.53-1.43],0.5916130332305586
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,22604,151,0.74 [0.41-1.32],0.3026380153930978
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22580,127,1.01 [0.54-1.91],0.963059498828591
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Umbilical hernia,20772,153,0.56 [0.32-0.98],0.0419799553690095
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17458,167,1.00 [0.58-1.74],0.9956612301101696
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ventral hernia,20844,225,1.94 [1.26-2.98],0.0026229334874834
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Volvulus,17368,77,1.09 [0.49-2.44],0.8323887367026152
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24149,221,1.39 [0.87-2.20],0.1645716098459905
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23940,74,1.93 [0.89-4.20],0.0977591673812705
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22412,200,1.32 [0.80-2.17],0.2701453739713765
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23742,552,1.62 [1.22-2.15],0.0009159690576794
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23322,132,2.69 [1.62-4.47],0.0001364716122272
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22497,285,1.71 [1.17-2.52],0.0058762638171361
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23942,248,1.48 [0.96-2.27],0.0755327632783177
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24121,427,1.49 [1.08-2.07],0.0156409056651568
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23739,45,0.84 [0.29-2.46],0.7569837944605979
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22810,2795,1.38 [1.21-1.57],1.7319480378214182e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23829,414,1.27 [0.91-1.79],0.1601135601613511
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23699,284,1.33 [0.89-2.00],0.1695163273953597
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23934,744,1.71 [1.34-2.17],1.5712879787771306e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24206,68,0.89 [0.38-2.11],0.7989816052526355
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22299,87,0.47 [0.22-1.01],0.0526710868644453
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23456,41,1.85 [0.66-5.20],0.2399876016904161
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23928,234,1.50 [0.97-2.34],0.0696649796942268
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22580,368,1.14 [0.79-1.64],0.4919948901163151
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22260,48,1.95 [0.78-4.84],0.1525071522250065
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24132,70,2.83 [1.50-5.33],0.0012923865830003
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23323,133,1.59 [0.89-2.85],0.120405504937656
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24016,150,1.36 [0.77-2.40],0.2912680818166814
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23738,44,2.30 [1.03-5.15],0.0419041540567689
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22270,58,0.57 [0.22-1.45],0.2339845657714049
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23624,1412,1.40 [1.17-1.67],0.0002700169679453
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22610,398,1.27 [0.90-1.80],0.1801616341595725
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22264,52,1.48 [0.58-3.78],0.4120780421832748
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24148,282,1.34 [0.89-2.03],0.1617129229003841
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23768,74,2.17 [1.06-4.47],0.0350682222372282
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24083,217,1.47 [0.92-2.35],0.1078764372396662
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24176,248,1.29 [0.84-2.01],0.2475912563529612
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22357,145,1.49 [0.84-2.67],0.1744504161137596
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22446,234,1.22 [0.77-1.93],0.4034799688704125
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24164,236,1.26 [0.80-1.98],0.3124259828829531
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22388,176,3.18 [2.19-4.61],9.8079172286287e-10
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24192,130,2.20 [1.29-3.76],0.0038863589131588
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20666,118,0.61 [0.32-1.17],0.137641914836314
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22004,5645,1.05 [0.95-1.15],0.3268243083796276
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20770,4411,1.08 [0.97-1.20],0.1788969705759245
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20615,67,0.73 [0.31-1.73],0.4697581826819074
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20776,137,1.25 [0.69-2.26],0.4657146121185056
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20825,186,1.53 [0.93-2.51],0.0935877505176802
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23975,102,1.86 [0.98-3.53],0.0563391493956661
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20743,104,1.24 [0.64-2.41],0.5276622451499314
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17577,1218,1.22 [1.00-1.49],0.0526016837551692
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24081,204,0.87 [0.53-1.42],0.5702334895107133
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21156,517,1.11 [0.82-1.51],0.4915607168386965
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20353,7194,1.05 [0.97-1.14],0.2602949090243113
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21699,119,1.39 [0.75-2.57],0.2949900766442611
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20670,122,0.62 [0.32-1.18],0.1423941911991781
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21162,614,0.94 [0.71-1.25],0.6782338207583507
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23312,2673,1.02 [0.89-1.17],0.7325074759365117
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20708,160,0.95 [0.55-1.67],0.8695192756226718
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20892,344,1.31 [0.90-1.91],0.1571047711599809
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20703,155,0.76 [0.43-1.35],0.3464959990418211
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23346,96,1.12 [0.55-2.25],0.7599787579295493
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18026,1667,1.12 [0.95-1.33],0.1754447368162063
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16543,184,1.06 [0.64-1.76],0.8099335809241351
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24212,181,0.92 [0.55-1.53],0.7368052280661627
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16454,95,1.11 [0.54-2.30],0.7781777803654029
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16874,515,1.03 [0.75-1.41],0.8540702575459012
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20847,299,0.77 [0.51-1.15],0.2007776324433091
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16921,562,0.91 [0.67-1.22],0.5284162835357986
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20698,59,1.95 [0.91-4.20],0.0880113393469916
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21272,633,1.03 [0.78-1.36],0.8469752362092763
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20934,295,0.75 [0.49-1.14],0.1748992527366244
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16880,521,0.87 [0.64-1.19],0.3908401595600166
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20623,75,0.88 [0.39-1.98],0.7555187785699212
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20608,60,0.71 [0.28-1.77],0.4628306161039928
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21624,44,0.88 [0.30-2.57],0.8196704536088264
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23806,2226,1.16 [1.00-1.35],0.042751601900926
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23185,1605,1.20 [1.01-1.42],0.0379128339705619
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24041,523,1.34 [1.00-1.80],0.0525092219488505
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19052,2693,1.16 [1.02-1.33],0.0273693613971133
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16421,62,0.33 [0.14-0.82],0.0169503652893243
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20639,91,1.20 [0.58-2.47],0.6217925450876425
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16401,42,2.33 [0.94-5.77],0.0677768910461817
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16540,181,1.49 [0.90-2.48],0.119610484489742
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21841,261,1.14 [0.74-1.74],0.5490408752429935
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22084,504,1.18 [0.87-1.61],0.2857383902259307
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24200,98,1.88 [0.99-3.57],0.0548192055542298
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22442,1803,0.98 [0.83-1.15],0.7950351756158168
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20663,115,1.47 [0.77-2.79],0.239064745817155
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16569,210,1.16 [0.71-1.88],0.5559823126690784
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21355,716,0.83 [0.64-1.09],0.1757731560933772
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18617,2258,0.99 [0.85-1.15],0.8819680027220735
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23366,116,1.22 [0.65-2.31],0.5321952010144106
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24206,73,1.85 [0.86-4.00],0.1166182010436399
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20614,66,1.21 [0.52-2.82],0.653959403703893
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21850,1302,1.03 [0.85-1.26],0.7307859875208947
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20622,74,0.71 [0.31-1.63],0.422417090911149
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18122,1763,1.12 [0.95-1.33],0.1661213298684214
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21709,129,0.59 [0.32-1.11],0.1009097478366538
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20596,48,0.99 [0.35-2.75],0.9796114844876848
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20817,178,1.14 [0.68-1.92],0.6153129108461355
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21055,507,1.13 [0.83-1.54],0.4349838787238249
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23706,456,0.86 [0.62-1.20],0.3811906261190172
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21206,567,1.32 [0.99-1.75],0.0599945222568367
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24053,505,1.33 [0.99-1.80],0.0616840650447721
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24199,58,0.92 [0.36-2.34],0.8584201623961316
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20748,200,0.96 [0.58-1.58],0.8691155870591607
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18572,811,1.04 [0.81-1.33],0.7767230978743509
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21134,586,0.84 [0.63-1.12],0.2399256286677395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20658,110,1.61 [0.84-3.08],0.1506430000263897
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16433,74,0.90 [0.40-2.04],0.795086488226597
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18699,2340,1.16 [1.00-1.33],0.0465137603811856
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17103,744,1.06 [0.82-1.37],0.6717316519247556
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23512,262,0.90 [0.58-1.39],0.6445341516260705
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24173,71,2.01 [0.96-4.18],0.0627562828365592
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22193,48,0.86 [0.32-2.34],0.7709659511338892
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16433,74,2.00 [0.92-4.31],0.0782973745116467
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20739,100,1.05 [0.52-2.12],0.8999501391830663
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16886,527,1.31 [0.98-1.76],0.0715255298845984
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20833,285,0.74 [0.49-1.12],0.1536737484709898
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20891,252,0.82 [0.52-1.28],0.3717997665609738
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20884,245,1.26 [0.81-1.94],0.3031667794671073
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18679,77,2.74 [1.46-5.16],0.0017136821576159
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24205,64,1.08 [0.45-2.60],0.860589242664269
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21112,564,0.80 [0.60-1.08],0.1511960419498844
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23398,148,0.71 [0.40-1.28],0.2569359642618216
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23047,2499,0.92 [0.80-1.06],0.2470975290762123
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20688,140,0.71 [0.39-1.30],0.2659299038499618
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21133,494,0.89 [0.65-1.22],0.4657160109677571
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22664,231,1.04 [0.66-1.65],0.8656937644067917
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20859,220,0.95 [0.59-1.53],0.8299818799867618
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22175,1536,1.04 [0.87-1.25],0.6514943860988839
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21682,1043,1.09 [0.88-1.36],0.4116536057433969
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20604,56,2.10 [0.92-4.79],0.078133668445948
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23467,217,1.00 [0.62-1.60],0.9932156806531937
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20728,180,1.05 [0.62-1.78],0.8466216349540825
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20666,118,0.78 [0.40-1.49],0.446433918485619
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16403,44,1.14 [0.40-3.22],0.8108757636570937
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23365,1047,1.38 [1.12-1.69],0.0020962680042231
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18108,87,0.88 [0.41-1.86],0.7294945054964654
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23610,101,1.06 [0.52-2.14],0.8716929310864148
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24083,205,1.18 [0.73-1.92],0.4981530455276374
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23901,23,1.49 [0.37-6.06],0.5739202096387876
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23491,1173,1.16 [0.95-1.41],0.1448826323637232
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24079,60,1.57 [0.69-3.57],0.2789760882335178
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24050,204,1.19 [0.74-1.91],0.4823846525703531
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cystitis,21394,221,0.88 [0.55-1.42],0.6101021990314361
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Dialysis,22363,45,1.96 [0.79-4.88],0.1487993592753033
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23797,288,1.48 [0.99-2.21],0.0562494643082239
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,18172,151,1.03 [0.58-1.82],0.9279826971909644
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18364,343,0.66 [0.46-0.97],0.0344709884791161
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18904,883,1.02 [0.80-1.29],0.8863474328073631
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18815,4369,1.09 [0.98-1.22],0.0970018962576174
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24072,53,2.60 [1.18-5.72],0.0178625763236411
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22195,182,0.91 [0.54-1.54],0.7240807652880288
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23732,349,1.12 [0.77-1.62],0.5556615270979799
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,23811,110,0.32 [0.17-0.62],0.0007173650606733
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18290,269,0.89 [0.58-1.36],0.579836469603293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21240,67,0.84 [0.35-2.01],0.6989295870811657
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20177,2156,0.95 [0.82-1.11],0.5262641319056793
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18143,122,1.20 [0.63-2.28],0.5715290363850712
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24215,57,0.67 [0.26-1.72],0.405174945547903
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24215,70,0.62 [0.26-1.46],0.2736860136738801
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23114,1941,1.10 [0.94-1.28],0.2470199414494436
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21589,416,0.92 [0.65-1.30],0.6171004272191871
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23608,99,2.20 [1.16-4.15],0.01516441667185
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24172,326,1.03 [0.70-1.51],0.8768756295859224
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24170,78,0.80 [0.35-1.79],0.5803197355221479
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22835,1662,1.15 [0.97-1.36],0.1084420789142451
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23565,182,1.17 [0.70-1.96],0.5473949989513103
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18159,138,1.65 [0.92-2.96],0.0906880215855145
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18367,346,0.79 [0.54-1.15],0.2159276042865849
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18125,104,0.90 [0.44-1.82],0.7715591373170381
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18204,183,0.56 [0.33-0.95],0.0317520438231639
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22239,226,1.10 [0.69-1.75],0.6921739646846439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23955,109,1.35 [0.71-2.56],0.3667376467107395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18288,267,1.13 [0.73-1.74],0.5889913343342503
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18114,93,1.18 [0.56-2.47],0.6705728013117915
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18588,567,1.04 [0.78-1.40],0.7808178105141155
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18163,142,0.77 [0.42-1.41],0.3986676587533796
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18541,520,1.18 [0.87-1.60],0.2894838277541296
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24053,34,1.21 [0.37-4.00],0.7520421965321655
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24068,2055,1.22 [1.05-1.42],0.008515693811384
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22159,146,2.14 [1.27-3.61],0.004145493185721
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22399,81,1.44 [0.69-3.00],0.3269139663654735
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23910,32,1.92 [0.61-6.05],0.265031754259491
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21303,130,0.87 [0.47-1.63],0.6736928926195089
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24114,236,1.25 [0.80-1.96],0.3238930154819195
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18144,123,1.36 [0.73-2.55],0.3356419647691543
